首页/数据集/Baseline demographics and clinical characteristics of patients receiving GSK1070806.

Baseline demographics and clinical characteristics of patients receiving GSK1070806.

Figshare2021-03-08 更新2026-04-28 收录

数据链接：

https://figshare.com/articles/dataset/Baseline_demographics_and_clinical_characteristics_of_patients_receiving_GSK1070806_/14180733 数据链接链接失效反馈

官方服务：

资源简介：

Baseline demographics and clinical characteristics of patients receiving GSK1070806.

应用场景：

创建时间：

2021-03-08

认知功能评估

患者基线特征

Baseline visit demographics: Participants demographics and cognitive scores at baseline visit.

NIAID Data Ecosystem70

Baseline and clinical characteristics of the study population according to the presence of DIC at JUMC from October 1, 2023, to September 30, 2024.

弥散性血管内凝血临床研究

患者基线特征

Baseline and clinical characteristics of the study population according to the presence of DIC at JUMC from October 1, 2023, to September 30, 2024.

Figshare2025-08-22 更新00

Dataset from A Phase 2, Randomized Study to Assess the Safety and Anti-cytomegalovirus (CMV) Activity of Different Doses of Maribavir for Treatment of CMV Infections That Are Resistant or Refractory to Treatment With Ganciclovir/Valganciclovir or Foscarnet in Transplant Recipients

移植后CMV感染

药物临床试验

This study will assess safety, antiviral activity, and pharmacokinetics of different doses of maribavir administered orally for up to 24 weeks for treatment of CMV infections that are resistant or r

NIAID Data Ecosystem00

Baseline demographic characteristics of patients.

患者基线特征

临床流行病学

S.D. = standard deviation; BMI = body mass index; $ = US dollarBaseline demographic characteristics of patients.

Figshare2015-12-03 更新10

Dataset from A Phase II, Randomised, Double-blind, Placebo-controlled, Multiple Dose Study to Evaluate Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Once Daily Oral Administration of BI 10773 (1 mg, 5 mg, 10 mg, and 25 mg) for 28 Days in Japanese Patients With Type 2 Diabetes Mellitus

药物临床试验

2型糖尿病治疗

The objective of this trial is to evaluate the pharmacodynamics, pharmacokinetics, safety, and tolerability of once daily oral administration of BI 10773 administered for 28 days in Japanese patients

NIAID Data Ecosystem00

Baseline demographics and clinical characteristics of patients receiving GSK1070806.

资源简介：

相关数据集